Effects of Upper Extremity-Focused Neuromuscular Training in People With Multiple Sclerosis
NCT ID: NCT06712342
Last Updated: 2024-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
72 participants
INTERVENTIONAL
2024-11-30
2025-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NEG
Upper Extremity Focused Neuromuscular Exercise Training
Neuromuscular Exercise Training
This group will receive neuromuscular exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks.
Warm-up Program - 5 minutes Postural Control-Weight Transfer - 10-15 minutes Strength Training - 30-35 minutes Proprioception - Coordination - Reaction Speed 10-15 minutes Cool-down Program - 5 minutes
CEG
Traditional Upper Extremity Exercise Training
Conventional Exercise Training
This group will be given traditional strength exercise training consisting of 60-75 minute sessions per day, 2 days per week for 8 weeks.
Warm-up Program - 5 minutes Strength Training - 30-35 minutes Manuel Dexterity - 15-20 minutes Cool-down Program - 5 minutes
CG
Control Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuromuscular Exercise Training
This group will receive neuromuscular exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks.
Warm-up Program - 5 minutes Postural Control-Weight Transfer - 10-15 minutes Strength Training - 30-35 minutes Proprioception - Coordination - Reaction Speed 10-15 minutes Cool-down Program - 5 minutes
Conventional Exercise Training
This group will be given traditional strength exercise training consisting of 60-75 minute sessions per day, 2 days per week for 8 weeks.
Warm-up Program - 5 minutes Strength Training - 30-35 minutes Manuel Dexterity - 15-20 minutes Cool-down Program - 5 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-64 years
* RRMS,
* EDSS \< 4,
* Minimal or moderate upper extremity involvement
Exclusion Criteria
* Mini Mental Test \<24 or visual deficit,
* Other medical conditions accompanying MS (cardiac, orthopedic or rheumatic, etc.),
* Being pregnant or breastfeeding,
* Doing regular exercise - receiving physiotherapy,
* Having spasticity of 2 or more in the upper extremity
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Aydın University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Uğur OVACIK
PT, MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uğur Ovacık
Role: PRINCIPAL_INVESTIGATOR
Istanbul Aydın University
Ela Tarakcı
Role: STUDY_DIRECTOR
Istanbul University - Cerrahpasa
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/125
Identifier Type: -
Identifier Source: org_study_id